CoChat

Benzodiazepine receptor binding of nonbenzodiazepines in vivo: Alpidem, zolpidem and zopiclone

Byrnes, John J., Greenblatt, David J., Miller, Lawrence G. · 1992 · Brain Research Bulletin

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Several classes of nonbenzodiazepine compounds, including imidazopyridines such as alpidem and zolpidem and cyclopyrrolones, e.g., zopiclone, have effects similar to benzodiazepines and may act at the benzodiazepine receptor in brain. We characterized the binding of these compounds to the benzodiazepine site in three brain regions using specific uptake of the high-affinity ligand [3H]Ro15-1788 (flumazenil). For alpidem, benzodiazepine binding was decreased in cortex and hippocampus with increasing drug dose. For zolpidem, receptor binding was reduced in cortex without a dose-response effect and no effect was observed on cerebellar binding. Zopiclone did not alter binding except for a decrease in binding at the lowest dose evaluated and an increase in binding above control at the highest dose. These data corroborate prior studies indicating that the imidazopyridines appear to act at the benzodiazepine receptor, but do not support receptor subtype selectivity of zolpidem. The limited effect of zopiclone except for increased binding at high doses is also consistent with prior studies suggesting that zopiclone acts at a site distinct from the benzodiazepine receptor.

Overview

Integrity signals

Registry

Crossref · 10.1016/0361-9230(92)90164-s

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Research works printed but not linked: 1

  1. Haefely, 1985, Recent advances in the molecular pharmacology of benzodiazepine receptors, Adv. Drug Res., 14, 165

Cited by

See all 49

Metadata

Authors
Byrnes, J. J., Greenblatt, D. J., & Miller, L. G.
Affiliations
Tufts University (US)
Corresponding author
Miller, Lawrence G.
Venue
Brain Research Bulletin
Publisher
Elsevier BV
Published
1992-12
Volume
29
Issue
6
Pages
905-908
ISSN
0361-9230 (ISSN-L)
OpenAlex
W2005020654
Cited by
46
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 2 · 2015: 3 · 2014: 1 · 2012: 2
FWCI
0.41
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Brain Research Bulletin (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01mh047598-03)
  • National Institute of Mental Health (MH-47598)
  • National Institute on Drug Abuse (DA05258)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords
benzodiazepine receptor, non-benzodiazepine hypnotics, alpidem, zolpidem, zopiclone, imidazopyridines, cyclopyrrolones, flumazenil binding, receptor binding, dose-response relationship, receptor subtype selectivity, hippocampus, cerebral cortex, cerebellum
MeSH terms
Zolpidem, Animals, Brain, Cerebellum, Cerebral Cortex, Dose-Response Relationship, Drug, Flumazenil, Hippocampus, Hypnotics and Sedatives, Imidazoles, Male, Mice, Inbred Strains, Piperazines, Pyridines, Receptors, GABA-A, Reference Values, Anti-Anxiety Agents, Mice, Azabicyclo Compounds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benzodiazepine receptor binding of nonbenzodiazepines in vivo: Alpidem, zolpidem and zopiclone. https://app.cochat.ai/papers/10.1016/0361-9230(92)90164-s
The paper
Byrnes, J. J., Greenblatt, D. J., & Miller, L. G. (1992). Benzodiazepine receptor binding of nonbenzodiazepines in vivo: Alpidem, zolpidem and zopiclone. Brain Research Bulletin. https://doi.org/10.1016/0361-9230(92)90164-s

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.